Several mechanisms by which malignant gliomas evade elimination by the immune system include reduced expression of antigen processing and presentation proteins; recruitment of suppressor myeloid and regulatory T cells (Tregs); production of immunosuppressive factors (i.e., prostaglandins), cytokines such as TGF-β1 (transforming growth factor beta 1), and interleukin (IL-10); and up-regulation of ligands for co-inhibitory receptors (i.e., PD-L1, Programmed death-ligand 1) that reduce activities of tumor-infiltrating T lymphocytes (TILs) [34,35]. The gene discussed is TGFB1; the disease is neoplasm.